Table 2.
Results from three validation runs
| | Thawed product | Final cell product post-enrichment | ||||
|---|---|---|---|---|---|---|
| viable CD34+ cells, n × 106 | viable CD34+ cells, n × 106 | CD34+ cell yield, % | CD34+ cell purity, % | CD34 + cell viability, % | CD3+ cell log depletion | |
| Run 1 | 189 | 107 | 57 | 94 | 97 | −5.1 |
| Run 2 | 150 | 81 | 54 | 91 | 99 | −5.0 |
| Run 3 | 234 | 115 | 49 | 94 | 96 | −5.4 |